Recommend Limiting Dose and Duration of NSAIDs in High-CV-Risk Patients

January 2017

Controversy will continue to brew over the safety of NSAIDs in patients at high cardiovascular risk.

All NSAIDs have a boxed warning about increased risk of CV events.

But the thinking has been that CV risk varies...with celecoxib (Celebrex, etc) more risky and naproxen the least risky.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote